Alzheimer’s Drug Development Comparable To Cancer 50 Years Ago – Targacept CEO
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Developing drugs to effectively treat Alzheimer's disease has been stymied by a failure to understand underlying causes of the disease, according to industry panelists at the BioInvestor Forum in San Francisco